Teresa Sevilla

Universitat de València — Spain

Neuroscience · Life Sciences

37h-index4.0kcitations160works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hereditary Neurological Disorders(63), Genetic Neurodegenerative Diseases(32), Neurogenetic and Muscular Disorders Research(27), Botulinum Toxin and Related Neurological Disorders(21), Peripheral Neuropathies and Disorders(20)

Publications159 total

O002 EFFECTS OF SPINAL CORD STIMULATION IN PATIENTS WITH SMALL FIBER NEUROPATHY FROM MULTIPLE ETIOLOGIES
Neuromodulation Technology at the Neural Interface·2026
Muscle MRI Contributes to the Differential Diagnosis Between Distal Myopathies and Distal Hereditary Motor Neuropathies
European Journal of Neurology·2026Open Access
Artificial intelligence for aortic valve calcium score quantification by echocardiography
2025Open Access
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy
Journal of Clinical Investigation·2025Open Access
Myasthenia gravis in Spain: A survey of specialized neurologists to uncover unmet needs
Neurología·2025Open Access
ID# 1888003 Effects of Spinal Cord Stimulation in Patients with Small Fiber Neuropathy From Multiple Etiologies
Neuromodulation Technology at the Neural Interface·2025
Neurofilaments as Biomarkers of the Efficacy of Risdiplam Treatment in Early SMA Phenotypes Diagnosed by Newborn Screening
Children·2025Open Access
502PA LGMDD2 muscular dystrophy pathological and transcriptomic study
Neuromuscular Disorders·2025
73PLong-term safety and efficacy of nipocalimab in generalized myasthenia gravis: vivacity-MG3 open-label extension phase results
Neuromuscular Disorders·2025
298PAnalysis of long-term clinical and MRI findings highlights progressive nature of Ano5-related myopathies and the role of imaging as a valuable outcome measure
Neuromuscular Disorders·2025
Small fiber neuropathy
Medicina Clínica (English Edition)·2025
Economic and healthcare resource utilization for hereditary transthyretin amyloidosis with polyneuropathy in Spain: real-world insights from early-stage patients and mutation carriers
Expert Review of Pharmacoeconomics & Outcomes Research·2025
Neuropatías de fibra pequeña
Medicina Clínica·2025· 2 cited
miR-107 represses DMPK and is sequestered by CUG repeats triggering the MSI2/miR-7 pathogenesis axis in myotonic dystrophy
Molecular Therapy — Nucleic Acids·2025Open Access
Long-term Safety and Efficacy of Nipocalimab in Generalized Myasthenia Gravis: Vivacity-MG3 Open-label Extension Phase Results (P7-11.022)
Neurology·2025· 2 cited
In Response to “Homogeneous <scp>ALS</scp> Cohorts in Terms of Etiology, Onset Type and Vaccination Status Are Required to Assess the Outcome of Their <scp>COVID</scp> Infection”
European Journal of Neurology·2025Open Access
Amiloidosis hereditaria por transtirretina por la variante Val142Ile en España
Revista Española de Cardiología·2025· 2 cited
Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD
Brain·2025· 6 citedOpen Access
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
The Lancet Neurology·2025· 48 cited
Effects of Spinal Cord Stimulation in Patients with Small Fiber and Associated Comorbidities from Neuropathy After Multiple Etiologies
Journal of Clinical Medicine·2025· 6 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Juan J. Vílchez(22), Carmen Espinós(17), Francesc Palau(15), Juan F. Vázquez‐Costa(13), María José Chumillas(12), Nuria Muelas(11), Vincenzo Lupo(11), Rafael Sivera(10), Luís Bataller(10), Julio Pardo(9), Ricard Rojas‐García(9), Dolores Martínez‐Rubio(9), Carlos Casasnovas(7), Isabel Illa(7), F. Mayordomo(6), Carmen Paradas(6), Adolfo López de Munaín(6), Marina Frasquet(6), Elena Cortés‐Vicente(5), Ivonne Jericó(5)